Let’s start up with the current stock price of DICE Therapeutics Inc. (DICE), which is $29.51 to be very precise. The Stock rose vividly during the last session to $29.79 after opening rate of $26.77 while the lowest price it went was recorded $26.625 before closing at $27.63.Recently in News on March 15, 2023, DICE Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights. IND application for DICE’s lead oral IL-17 antagonist, DC-806, cleared by FDA; global Phase 2b clinical trial in patients with moderate-to-severe psoriasis on track to initiate in 1H 2023. You can read further details here
DICE Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $45.99 on 10/11/22, with the lowest value was $12.64 for the same time period, recorded on 06/16/22.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
DICE Therapeutics Inc. (DICE) full year performance was 72.78%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, DICE Therapeutics Inc. shares are logging -35.83% during the 52-week period from high price, and 133.56% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $12.64 and $45.99.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 669676 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the DICE Therapeutics Inc. (DICE) recorded performance in the market was -5.42%, having the revenues showcasing -12.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.44B, as it employees total of 65 workers.
DICE Therapeutics Inc. (DICE) in the eye of market guru’s
During the last month, 8 analysts gave the DICE Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 31.60, with a change in the price was noted -4.23. In a similar fashion, DICE Therapeutics Inc. posted a movement of -12.54% for the period of last 100 days, recording 455,940 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for DICE is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
DICE Therapeutics Inc. (DICE): Stocks Technical analysis and Trends
Raw Stochastic average of DICE Therapeutics Inc. in the period of last 50 days is set at 50.66%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.73%. In the last 20 days, the company’s Stochastic %K was 38.24% and its Stochastic %D was recorded 29.74%.
If we look into the earlier routines of DICE Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -5.42%. Additionally, trading for the stock in the period of the last six months notably improved by 50.48%, alongside a boost of 72.78% for the period of the last 12 months. The shares increased approximately by 9.95% in the 7-day charts and went up by 0.44% in the period of the last 30 days. Common stock shares were lifted by -12.80% during last recorded quarter.
